Stay updated with breaking news from Adv. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
President Cyril Ramaphosa on Saturday said any action by the president that is deemed invalid must be adjudicated by the Constitutional Court.
35 Percent of Patients Treated With CTP-543 12 mg Twice-Daily Achieved At Least 90 Percent Scalp Hair Coverage (SALT Score 10) After 24 Weeks of Treatment Newly-Reported Results Show Significant
President Cyril Ramaphosa on Saturday said any action by the president that is deemed invalid must be adjudicated by the Constitutional Court.
Dupixent (dupilumab) late-breaking Phase 3 data at EADV 2022 showed significant improvements in signs and symptoms of prurigo nodularis Nearly three times as many Dupixent patients experienced
An interim safety analysis from ECZTEND, an open-label, 5-year extension trial, demonstrated consistent safety from the parent trials for up to 3.5 years of Adbry (tralokinumab-ldrm) treatment in